Research Article
Impact of Cytological Sampling on EGFR Mutation Testing in Stage III-IV Lung Adenocarcinoma
Table 2
Source of sample for diagnosis.
| ā | ā | Sent for EGFR mutation testing | Successful mutation analysis | | | % | | % |
| Histological | 45 | 37 | 82 | 30 | 81 | CT guided lung biopsy | 17 | 14 | 82 | 11 | 79 | Bronchoscopic biopsy | 12 | 9 | 75 | 8 | 89 | CT guided bone biopsy | 3 | 3 | 100 | 3 | 100 | Wedge resection | 2 | 2 | 100 | 0 | 0 | Excision biopsy neck node | 2 | 2 | 100 | 2 | 100 | Biopsy of metastasis | 2 | 2 | 100 | 2 | 100 | Lobectomy | 1 | 1 | 100 | 1 | 100 | VATS biopsy lung | 1 | 0 | 0 | 0 | 0 | Core biopsy node | 1 | 1 | 100 | 1 | 100 | Bone biopsy | 3 | 2 | 67 | 1 | 33 | Endoscopic biopsy of oesophagus | 1 | 1 | 100 | 1 | 100 | Cytological | 25 | 22 | 88 | 20 | 91 | Pleural fluid | 11 | 10 | 91 | 9 | 90 | EBUS TBNA node | 9 | 8 | 89 | 8 | 100 | Bronchial washings | 2 | 1 | 50 | 0 | 0 | CT guided FNA lung | 1 | 1 | 100 | 1 | 100 | EUS FNA node | 1 | 1 | 100 | 1 | 100 | FNA node | 1 | 1 | 100 | 1 | 100 |
|
|